N/A N=82 Randomized Double-blind Treatment

Two Standardized Radial Pressure Wave Techniques Versus Pain-Site Guided Therapy in Patients With Knee Osteoarthritis.

Osteoarthritis, Knee

Bottom Line

View on ClinicalTrials.gov: NCT06622512 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

May 2026

Primary outcome: Primary: Pain Intensity — 4.81; 4.52; 5.73 Score (0-10)

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Radial Pressure Wave Therapy (Device)
Age: Adult, Older Adult · 50+ yrs
Sex: All
Sponsor: Hospital Civil de Guadalajara
Primary completion: Jan 2025

Outcome Measures

Outcome	Result	p-value
PRIMARY Pain Intensity	4.81; 4.52; 5.73	—
PRIMARY Self-reported Disability	32.19; 30.26; 40.05	—

Summary

The goal of this clinical trial is to evaluate and compare the effectiveness of radial pressure wave therapy (RPWT) applied at different anatomical sites in patients with knee osteoarthritis (OA) over a follow-up of four months. The main questions it aims to answer are: How effective is the application of RPWT on the medial and lateral interarticular lines in patients with knee OA? Are standardized RPWT application techniques on interarticular lines superior to the traditional application technique on the points of greatest pain in patients with knee OA? Researchers will compare the effectiveness of two standardized application techniques on interarticular lines to decrease pain and improve function in patients with knee OA. Participants will receive three sessions of RPWT on the most painful knee as a result of knee OA.

Eligibility Criteria

Inclusion Criteria

Chronic and current knee pain.
Clinical and radiographic diagnosis of knee OA.

Exclusion Criteria

History of knee surgery.
Inflammatory arthropathy.
Septic arthritis.
Fibromyalgia.
Cancer.
Severe vascular insufficiency

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06622512). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.